DE68916443D1 - Arzneimittel zur behandlung von kryptosporidiose. - Google Patents

Arzneimittel zur behandlung von kryptosporidiose.

Info

Publication number
DE68916443D1
DE68916443D1 DE68916443T DE68916443T DE68916443D1 DE 68916443 D1 DE68916443 D1 DE 68916443D1 DE 68916443 T DE68916443 T DE 68916443T DE 68916443 T DE68916443 T DE 68916443T DE 68916443 D1 DE68916443 D1 DE 68916443D1
Authority
DE
Germany
Prior art keywords
cryptosporidiosis
medicines
treating
prophylaxis
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68916443T
Other languages
English (en)
Other versions
DE68916443T2 (de
Inventor
Victoria Latter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE68916443D1 publication Critical patent/DE68916443D1/de
Publication of DE68916443T2 publication Critical patent/DE68916443T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE68916443T 1989-10-16 1989-10-26 Arzneimittel zur behandlung von kryptosporidiose. Expired - Fee Related DE68916443T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898923254A GB8923254D0 (en) 1989-10-16 1989-10-16 Medicaments
PCT/GB1989/001287 WO1991005550A1 (en) 1989-10-16 1989-10-26 Medicament for the treatment of cryptosporidiosis

Publications (2)

Publication Number Publication Date
DE68916443D1 true DE68916443D1 (de) 1994-07-28
DE68916443T2 DE68916443T2 (de) 1994-12-22

Family

ID=10664644

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68916443T Expired - Fee Related DE68916443T2 (de) 1989-10-16 1989-10-26 Arzneimittel zur behandlung von kryptosporidiose.

Country Status (14)

Country Link
EP (1) EP0496729B1 (de)
JP (1) JPH05502435A (de)
KR (1) KR920703038A (de)
AT (1) ATE107504T1 (de)
AU (1) AU637772B2 (de)
CA (1) CA2001566A1 (de)
DE (1) DE68916443T2 (de)
DK (1) DK50092A (de)
GB (1) GB8923254D0 (de)
HU (1) HU208625B (de)
IE (1) IE893450A1 (de)
MC (1) MC2203A1 (de)
WO (1) WO1991005550A1 (de)
ZA (1) ZA898143B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
GB9613309D0 (en) * 1996-06-25 1996-08-28 Univ Sheffield Quinone bacterial inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents

Also Published As

Publication number Publication date
JPH05502435A (ja) 1993-04-28
MC2203A1 (fr) 1992-11-26
EP0496729B1 (de) 1994-06-22
AU637772B2 (en) 1993-06-10
GB8923254D0 (en) 1989-12-06
CA2001566A1 (en) 1991-04-16
ZA898143B (en) 1991-06-26
HUT60431A (en) 1992-09-28
ATE107504T1 (de) 1994-07-15
HU9201295D0 (en) 1992-07-28
DK50092D0 (da) 1992-04-14
IE893450A1 (en) 1991-04-24
AU4519289A (en) 1991-05-16
WO1991005550A1 (en) 1991-05-02
DE68916443T2 (de) 1994-12-22
HU208625B (en) 1993-12-28
DK50092A (da) 1992-04-14
EP0496729A1 (de) 1992-08-05
KR920703038A (ko) 1992-12-17

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69602412D1 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
RU98101105A (ru) Новое применение в медицинских целях
KR930019224A (ko) 유산 위험 치료제
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
RU93052444A (ru) Лекарственный препарат бан
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee